Previous studies have considered fibronectin as a biomarker for some diseases, such as sepsis, where low fibronectin levels seem to be a marker of poor prognosis, and meningitis and asthma, where fibronectin levels are significantly increased (34, 35). This evidence concerns the gene FN1 and Sepsis.